Results 31 to 40 of about 18,269 (215)

SBRT pancreas

, 2022
Introduction: In order to deliver a better and better dose to the region of interest, the SBRT method of pancreatic irradiation was introduced. Goal: Precise delivery of a high dose to a small volume with a small number of fractions. The role of the radiotherapy technician during each segment of the entire process, as well as all the specifics of the ...
openaire   +1 more source

Radiotherapy and Immunotherapy In Hepatocellular Carcinoma: Priming the Tumor Immune Microenvironment From Bench To Bedside

Precision Radiation Oncology, EarlyView.
The dual immunomodulatory network of radiotherapy in hepatocellular carcinoma. Radiotherapy initiates its effects by inducing immunogenic cell death and DNA double‐strand breaks. Immune Activation: Cytosolic DNA from damaged cells activates the cGAS‐STING pathway, triggering IRF3/NF‐κB‐mediated type I interferon production. This enhances dendritic cell
Zhigang Fu, Yang Zhang, Zuomin Wang, Zongjuan Li, Shisuo Du   +4 more
wiley   +1 more source

NRG Oncology Survey on Practice and Technology Use in SRT and SBRT Delivery

Frontiers in Oncology, 2020
PurposeTo assess stereotactic radiotherapy (SRT)/stereotactic body radiotherapy (SBRT) practices by polling clinics participating in multi-institutional clinical trials.MethodsThe NRG Oncology Medical Physics Subcommittee distributed a survey consisting ...
Mikhail Chetvertkov, James Ira Monroe, Jaskaran Boparai, Timothy D. Solberg, Deanna H. Pafundi, Russell L. Ruo, David J. Gladstone, Fang-Fang Yin, Indrin J. Chetty, Stanley Benedict, David S. Followill, Ying Xiao, Jason W. Sohn   +12 more
doaj   +1 more source

T-Cell Receptor Profiling and Prognosis After Stereotactic Body Radiation Therapy For Stage I Non-Small-Cell Lung Cancer

Frontiers in Immunology, 2021
Radiotherapy is known to influence immune function, including T cell receptor (TCR) repertoire. We evaluated the TCR repertoire before and after stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer (NSCLC) and explored ...
Lirong Wu, Lirong Wu, Jun Zhu, Nils-Petter Rudqvist, Nils-Petter Rudqvist, James Welsh, Percy Lee, Zhongxing Liao, Ting Xu, Ming Jiang, Xiangzhi Zhu, Xuan Pan, Pansong Li, Zhipeng Zhou, Xia He, Rong Yin, Rong Yin, Jifeng Feng   +17 more
doaj   +1 more source

Interventional Radiology Society of Australasia Quality Care Guidelines for Renal Tumour Ablation in Australia and New Zealand

Journal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT Image‐guided thermal ablation (radiofrequency, cryo‐ and microwave ablation) is a safe and effective primary treatment for small renal mass and localised renal cell carcinoma ≤ 4 cm (T1a) with long‐term cancer‐specific survival rates equivalent to surgical resection (Level A).
Matthew Lukies, William Ormiston, Nicholas Brown, Philip Chan, Ahmad Al‐Hindawi, Radha Popuri, Brendan Buckley   +6 more
wiley   +1 more source

Single-Fraction Radiotherapy (SFRT) For Bone Metastases: Patient Selection And Perspectives

Cancer Management and Research, 2019
Mauro Loi,1 Joost J Nuyttens,2 Isacco Desideri,1 Daniela Greto,1 Lorenzo Livi1 1Radiotherapy Department, University of Florence, Florence, Italy; 2Radiotherapy Department, Erasmus MC Cancer Center, Rotterdam, The NetherlandsCorrespondence: Mauro ...
Loi M, Nuyttens JJ, Desideri I, Greto D, Livi L   +4 more
doaj  

Lung V5 and Planning Target Volume/Lung Volume Ratio as Independent Risk Factors for ≥Grade 2 Radiation Pneumonitis after Moderately Hypofractionated Radiotherapy: A Retrospective Study

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Lung V5 and the planning target volume/lung volume ratio were identified as independent dosimetric risk factors for clinically significant radiation pneumonitis following moderately hypofractionated radiotherapy for lung cancer. Maintaining V5 < 35% may help mitigate this risk in clinical practice.
YuanYou Yang, FengXia Luo, Chao Wang, Gang Ren   +3 more
wiley   +1 more source

Ablative radiotherapy in castration‐resistant prostate cancer

BJU International, EarlyView.
Objective To prove the oncological benefit of ablative radiotherapy in patients with up to five metastases from castration‐resistant prostate cancer (CRPC) a single‐centre randomised trial was initiated. Patients and Methods This monocentric, randomised, phase II clinical trial enrolled patients with up to five prostate‐specific membrane antigen ...
Tobias Hölscher, Fabian Lohaus, Lydia Koi, Jörg Kotzerke, Sebastian Hoberück, Christian Thomas, Angelika Borkowetz, Steffen Löck, Mechthild Krause, Esther G.C. Troost   +9 more
wiley   +1 more source

Descriptive analysis of screen‐detected versus clinically diagnosed lung cancer cases: evidence of earlier stage shift and treatment differences

Internal Medicine Journal, EarlyView.
Abstract Background Lung cancer is the leading cause of cancer‐related deaths worldwide, largely due to late‐stage diagnosis. Lung cancer screening by computed tomography (CT) reduces mortality by detecting cancers earlier in high‐risk individuals, prompting Australia to launch the National Lung Cancer Screening Program (NLCSP) in 2025.
Jazmin Guayco Sigcha, Tian Mun Chee, Ian A. Yang, Linda Passmore, Kwun M. Fong, Henry M. Marshall   +5 more
wiley   +1 more source

Bridging hope: Retrospective analysis of stereotactic radiotherapy in patients with hepatocellular carcinoma-A promising and cost-effective solution for low-and middle-income countries

Cancer Research, Statistics, and Treatment
Background: Hepatocellular carcinoma (HCC) is one of the most common cancers among men in India. Stereotactic body radiation therapy (SBRT) has recently become a promising treatment modality for HCC before liver transplantation.
Rakesh Kapoor, Treshita Dey, Divya Khosla, Sunil Taneja, Naveen Kalra, Rajesh Gupta   +5 more
doaj   +1 more source